Oral contraceptive use and benign gynecologic conditions: A review

Francesca Chiaffarino, Fabio Parazzini, Carlo L. La Vecchia, Elena Ricci, Pier Giorgio Crosignani

Research output: Contribution to journalArticle

Abstract

The following review considers the main epidemiologic data on oral contraceptives (OC) and the risk of major benign gynecologic diseases. Earlier studies investigating the relationship between OC use and functional ovarian cysts indicated that the use of high-dose combination OC have a protective effect, whereas low-dose monophasic or multiphasic pills have little or no effect. With regard to seromucinous cysts, the scanty data available are consistent with the notion of some protection of OC in current but not in former users, although possible effects of diagnostic and selection bias should be considered. Published data on the relationship between fibroids and OC appear too scattered to allow a precise quantification of risk. In any case, any relationship is moderate and, hence, of limited clinical and public health relevance. The data on OC and benign gynecologic conditions are reassuring in their absence of any consistent excess risk.

Original languageEnglish
Pages (from-to)11-18
Number of pages8
JournalContraception
Volume57
Issue number1
DOIs
Publication statusPublished - Jan 1998

Fingerprint

Oral Contraceptives
Female Genital Diseases
Ovarian Cysts
Selection Bias
Leiomyoma
Cysts
Public Health

Keywords

  • Oral contraceptive benign gynecologic disease

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynaecology

Cite this

Oral contraceptive use and benign gynecologic conditions : A review. / Chiaffarino, Francesca; Parazzini, Fabio; La Vecchia, Carlo L.; Ricci, Elena; Crosignani, Pier Giorgio.

In: Contraception, Vol. 57, No. 1, 01.1998, p. 11-18.

Research output: Contribution to journalArticle

Chiaffarino, Francesca ; Parazzini, Fabio ; La Vecchia, Carlo L. ; Ricci, Elena ; Crosignani, Pier Giorgio. / Oral contraceptive use and benign gynecologic conditions : A review. In: Contraception. 1998 ; Vol. 57, No. 1. pp. 11-18.
@article{5da3c82328e74ae8a05ec7a482d84a5f,
title = "Oral contraceptive use and benign gynecologic conditions: A review",
abstract = "The following review considers the main epidemiologic data on oral contraceptives (OC) and the risk of major benign gynecologic diseases. Earlier studies investigating the relationship between OC use and functional ovarian cysts indicated that the use of high-dose combination OC have a protective effect, whereas low-dose monophasic or multiphasic pills have little or no effect. With regard to seromucinous cysts, the scanty data available are consistent with the notion of some protection of OC in current but not in former users, although possible effects of diagnostic and selection bias should be considered. Published data on the relationship between fibroids and OC appear too scattered to allow a precise quantification of risk. In any case, any relationship is moderate and, hence, of limited clinical and public health relevance. The data on OC and benign gynecologic conditions are reassuring in their absence of any consistent excess risk.",
keywords = "Oral contraceptive benign gynecologic disease",
author = "Francesca Chiaffarino and Fabio Parazzini and {La Vecchia}, {Carlo L.} and Elena Ricci and Crosignani, {Pier Giorgio}",
year = "1998",
month = "1",
doi = "10.1016/S0010-7824(97)00201-1",
language = "English",
volume = "57",
pages = "11--18",
journal = "Contraception",
issn = "0010-7824",
publisher = "Elsevier USA",
number = "1",

}

TY - JOUR

T1 - Oral contraceptive use and benign gynecologic conditions

T2 - A review

AU - Chiaffarino, Francesca

AU - Parazzini, Fabio

AU - La Vecchia, Carlo L.

AU - Ricci, Elena

AU - Crosignani, Pier Giorgio

PY - 1998/1

Y1 - 1998/1

N2 - The following review considers the main epidemiologic data on oral contraceptives (OC) and the risk of major benign gynecologic diseases. Earlier studies investigating the relationship between OC use and functional ovarian cysts indicated that the use of high-dose combination OC have a protective effect, whereas low-dose monophasic or multiphasic pills have little or no effect. With regard to seromucinous cysts, the scanty data available are consistent with the notion of some protection of OC in current but not in former users, although possible effects of diagnostic and selection bias should be considered. Published data on the relationship between fibroids and OC appear too scattered to allow a precise quantification of risk. In any case, any relationship is moderate and, hence, of limited clinical and public health relevance. The data on OC and benign gynecologic conditions are reassuring in their absence of any consistent excess risk.

AB - The following review considers the main epidemiologic data on oral contraceptives (OC) and the risk of major benign gynecologic diseases. Earlier studies investigating the relationship between OC use and functional ovarian cysts indicated that the use of high-dose combination OC have a protective effect, whereas low-dose monophasic or multiphasic pills have little or no effect. With regard to seromucinous cysts, the scanty data available are consistent with the notion of some protection of OC in current but not in former users, although possible effects of diagnostic and selection bias should be considered. Published data on the relationship between fibroids and OC appear too scattered to allow a precise quantification of risk. In any case, any relationship is moderate and, hence, of limited clinical and public health relevance. The data on OC and benign gynecologic conditions are reassuring in their absence of any consistent excess risk.

KW - Oral contraceptive benign gynecologic disease

UR - http://www.scopus.com/inward/record.url?scp=0031899417&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031899417&partnerID=8YFLogxK

U2 - 10.1016/S0010-7824(97)00201-1

DO - 10.1016/S0010-7824(97)00201-1

M3 - Article

C2 - 9554245

AN - SCOPUS:0031899417

VL - 57

SP - 11

EP - 18

JO - Contraception

JF - Contraception

SN - 0010-7824

IS - 1

ER -